XML 17 R70.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONDENSED CONSOLIDATING INFORMATION - Statement of Income (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Dec. 31, 2014
Revenues:          
Rental income $ 343,783 $ 287,559 $ 991,878 $ 846,989  
Resident fees and services 454,825 396,247 1,356,384 1,141,781  
Medical office building and other services revenue 10,000 7,573 29,951 18,240  
Income from loans and investments 18,924 13,186 66,192 36,902  
Equity earnings in affiliates 0 0 0 0  
Interest and other income 74 367 719 811  
Total revenues 827,606 704,932 2,445,124 2,044,723  
Expenses:          
Interest 97,135 77,325 263,422 214,117  
Depreciation and amortization 226,332 173,006 657,262 507,167  
Property-level operating expenses 347,845 306,536 1,031,306 883,014  
Medical office building services costs 6,416 4,568 19,098 9,565  
General, administrative and professional fees 32,114 29,464 100,399 93,632  
(Gain) loss on extinguishment of debt, net 15,331 2,414 14,897 5,079  
Merger-related expenses and deal costs 62,145 16,188 105,023 35,944  
Other 4,795 9,413 13,948 18,070  
Total expenses 792,113 618,914 2,205,355 1,766,588  
Income before (loss) income from unconsolidated entities, income taxes, discontinued operations, real estate dispositions and noncontrolling interest 35,493 86,018 239,769 278,135  
Income (loss) from unconsolidated entities (955) (47) (1,197) 549  
Income tax benefit (expense) 10,697 1,887 27,736 (4,820)  
Income from continuing operations 45,235 87,858 266,308 273,864  
Discontinued operations (22,383) 18,171 13,434 79,026  
Gain on real estate dispositions 265 3,625 14,420 16,514  
Net income 23,117 109,654 294,162 369,404 $ 477,186
Net income attributable to noncontrolling interest 265 522 1,047 827  
Net income attributable to common stockholders 22,852 109,132 293,115 368,577  
Ventas, Inc.          
Revenues:          
Rental income 916 626 2,747 1,873  
Resident fees and services 0 0 0 0  
Medical office building and other services revenue 293 0 293 0  
Income from loans and investments 50 1,049 8,655 2,285  
Equity earnings in affiliates 99,873 124,738 360,988 383,245  
Interest and other income 106 109 482 294  
Total revenues 101,238 126,522 373,165 387,697  
Expenses:          
Interest (10,788) (6,199) (27,548) (11,071)  
Depreciation and amortization 1,347 1,489 4,047 4,387  
Property-level operating expenses 0 0 0 0  
Medical office building services costs 0 0 0 0  
General, administrative and professional fees (678) 1,147 (598) 3,022  
(Gain) loss on extinguishment of debt, net 0 0 0 (3)  
Merger-related expenses and deal costs 62,007 13,403 101,306 21,035  
Other 271 6,932 453 7,055  
Total expenses 52,159 16,772 77,660 24,425  
Income before (loss) income from unconsolidated entities, income taxes, discontinued operations, real estate dispositions and noncontrolling interest 49,079 109,750 295,505 363,272  
Income (loss) from unconsolidated entities 0 0 0 0  
Income tax benefit (expense) 10,697 1,887 27,736 (4,820)  
Income from continuing operations 59,776 111,637 323,241 358,452  
Discontinued operations (37,189) (6,130) (44,546) (6,389)  
Gain on real estate dispositions 265 3,625 14,420 16,514  
Net income 22,852 109,132 293,115 368,577  
Net income attributable to noncontrolling interest 0 0 0 0  
Net income attributable to common stockholders $ 22,852 109,132 $ 293,115 368,577  
Ventas Realty          
Condensed financial statements, captions          
Ownership percentage 100.00%   100.00%    
Revenues:          
Rental income $ 49,425 44,873 $ 148,833 133,346  
Resident fees and services 0 0 0 0  
Medical office building and other services revenue 0 0 0 0  
Income from loans and investments 180 0 483 0  
Equity earnings in affiliates 0 0 0 0  
Interest and other income (2) 10 (6) 21  
Total revenues 49,603 44,883 149,310 133,367  
Expenses:          
Interest 67,521 49,011 189,716 133,215  
Depreciation and amortization 3,455 3,831 11,394 11,839  
Property-level operating expenses 81 141 285 388  
Medical office building services costs 0 0 0 0  
General, administrative and professional fees 5,225 5,067 16,640 15,975  
(Gain) loss on extinguishment of debt, net 4,523 0 4,523 3  
Merger-related expenses and deal costs 0 0 75 2,110  
Other 5 0 49    
Total expenses 80,810 58,050 222,682 163,530  
Income before (loss) income from unconsolidated entities, income taxes, discontinued operations, real estate dispositions and noncontrolling interest (31,207) (13,167) (73,372) (30,163)  
Income (loss) from unconsolidated entities (469) 315 291 1,156  
Income tax benefit (expense) 0 0 0 0  
Income from continuing operations (31,676) (12,852) (73,081) (29,007)  
Discontinued operations 7,371 15,082 34,748 47,694  
Gain on real estate dispositions 0 0 0 0  
Net income (24,305) 2,230 (38,333) 18,687  
Net income attributable to noncontrolling interest 0 0 0 0  
Net income attributable to common stockholders $ (24,305) $ 2,230 $ (38,333) $ 18,687  
Ventas Capital Corporation          
Condensed financial statements, captions          
Ownership percentage 100.00% 100.00% 100.00% 100.00% 100.00%
Ventas Subsidiaries          
Revenues:          
Rental income $ 293,442 $ 242,060 $ 840,298 $ 711,770  
Resident fees and services 454,825 396,247 1,356,384 1,141,781  
Medical office building and other services revenue 9,707 7,573 29,658 18,240  
Income from loans and investments 18,694 12,137 57,054 34,617  
Equity earnings in affiliates (243) 22 (383) 187  
Interest and other income (30) 248 243 496  
Total revenues 776,395 658,287 2,283,254 1,907,091  
Expenses:          
Interest 40,402 34,513 101,254 91,973  
Depreciation and amortization 221,530 167,686 641,821 490,941  
Property-level operating expenses 347,764 306,395 1,031,021 882,626  
Medical office building services costs 6,416 4,568 19,098 9,565  
General, administrative and professional fees 27,567 23,250 84,357 74,635  
(Gain) loss on extinguishment of debt, net 10,808 2,414 10,374 5,079  
Merger-related expenses and deal costs 138 2,785 3,642 12,799  
Other 4,519 2,481 13,446 11,015  
Total expenses 659,144 544,092 1,905,013 1,578,633  
Income before (loss) income from unconsolidated entities, income taxes, discontinued operations, real estate dispositions and noncontrolling interest 117,251 114,195 378,241 328,458  
Income (loss) from unconsolidated entities (486) (362) (1,488) (607)  
Income tax benefit (expense) 0 0 0 0  
Income from continuing operations 116,765 113,833 376,753 327,851  
Discontinued operations 7,435 9,219 23,232 37,721  
Gain on real estate dispositions 0 0 0 0  
Net income 124,200 123,052 399,985 365,572  
Net income attributable to noncontrolling interest 265 522 1,047 827  
Net income attributable to common stockholders 123,935 122,530 398,938 364,745  
Consolidated Eliminations          
Revenues:          
Rental income 0 0 0 0  
Resident fees and services 0 0 0 0  
Medical office building and other services revenue 0 0 0 0  
Income from loans and investments 0 0 0 0  
Equity earnings in affiliates (99,630) (124,760) (360,605) (383,432)  
Interest and other income 0 0 0 0  
Total revenues (99,630) (124,760) (360,605) (383,432)  
Expenses:          
Interest 0 0 0 0  
Depreciation and amortization 0 0 0 0  
Property-level operating expenses 0 0 0 0  
Medical office building services costs 0 0 0 0  
General, administrative and professional fees 0 0 0 0  
(Gain) loss on extinguishment of debt, net 0 0 0 0  
Merger-related expenses and deal costs 0 0 0 0  
Other 0 0 0 0  
Total expenses 0 0 0 0  
Income before (loss) income from unconsolidated entities, income taxes, discontinued operations, real estate dispositions and noncontrolling interest (99,630) (124,760) (360,605) (383,432)  
Income (loss) from unconsolidated entities 0 0 0 0  
Income tax benefit (expense) 0 0 0 0  
Income from continuing operations (99,630) (124,760) (360,605) (383,432)  
Discontinued operations 0 0 0 0  
Gain on real estate dispositions 0 0 0 0  
Net income (99,630) (124,760) (360,605) (383,432)  
Net income attributable to noncontrolling interest 0 0 0 0  
Net income attributable to common stockholders $ (99,630) $ (124,760) $ (360,605) $ (383,432)